A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis. [electronic resource]
Producer: 20020604Description: 415-23 p. digitalISSN:- 0269-2813
- Adolescent
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Colitis, Ulcerative -- drug therapy
- Dosage Forms
- Endoscopy, Gastrointestinal
- Enema -- adverse effects
- Female
- Humans
- Male
- Mesalamine -- administration & dosage
- Middle Aged
- Patient Compliance
- Patient Satisfaction
- Quality of Life
- Remission Induction
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.